Donepezil improves cognition in patients with vascular dementia: Results from study 307, a 24-week, randomized, double-blind, placebo-controlled trial

被引：0
|
作者：
Roman, GC
Pratt, RD
Perdomo, CA
Perdomo, CA
机构：
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
[2] Eisai Inc, Teaneck, NJ USA
来源：
NEUROBIOLOGY OF AGING | 2002年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
212
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [21] A 24-week randomized, double-blind, placebo-controlled study of the efficacy and tolerability of TNFR: Fc (etanercept) in the treatment of dementia of the Alzheimer type
    Bohac, D
    Burke, W
    Cotter, R
    Zheng, J
    Potter, J
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S83 - S83
  • [22] A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder
    Montgomery, SA
    Nil, R
    Dürr-Pal, N
    Loft, H
    Boulenger, JP
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (10) : 1270 - 1278
  • [23] A randomised, double-blind, placebo-controlled 24-week trial of aripiprazole in recently remitted bipolar I patients
    Bahk, W. M.
    Woo, Y. S.
    Chung, M. Y.
    Kim, D. H.
    Yoon, B. H.
    Lee, J. H.
    Ahn, Y. M.
    Kim, J. K.
    Lee, K. H.
    Min, K. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S482 - S482
  • [24] LIPID MANAGEMENT IN A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ALDAFERMIN (NGM282)
    Gunn, Nadege T.
    Ling, Lei
    Neff, Guy
    Guy, Cynthia D.
    Bashir, Mustafa
    Frias, Juan Pablo
    Younes, Ziad H.
    Trotter, James F.
    Moussa, Sam
    Kohli, Anita
    Connelly, Margery A.
    Nelson, Kristin
    Gottwald, Mildred
    Chang, William
    Yan, Andrew Z.
    DePaoli, Alex
    Lieu, Hsiao
    Harrison, Stephen A.
    HEPATOLOGY, 2020, 72 : 1022 - 1023
  • [25] Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease - Results of a 24-week, double-blind, placebo-controlled study
    Tune, L
    Tiseo, PJ
    Ieni, J
    Perdomo, C
    Pratt, RD
    Votaw, JR
    Jewart, RD
    Hoffman, JM
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 11 (02): : 169 - 177
  • [26] Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial
    Usall, Judith
    Huerta-Ramos, Elena
    Labad, Javier
    Cobo, Jesus
    Nunez, Christian
    Creus, Marta
    Garcia Pares, Gemma
    Cuadras, Daniel
    Franco, Jose
    Miquel, Eva
    Cesar Reyes, Julio
    Roca, Mercedes
    SCHIZOPHRENIA BULLETIN, 2016, 42 (02) : 309 - 317
  • [27] Scalp application of antioxidants improves scalp condition and reduces hair shedding in a 24-week randomized, double-blind, placebo-controlled clinical trial
    Davis, Michael G.
    Piliang, Melissa P.
    Bergfeld, Wilma F.
    Caterino, Tamara L.
    Fisher, Brian K.
    Sacha, Jarek P.
    Carr, Gregory J.
    Moulton, Laura T.
    Whittenbarger, Deborah J.
    Schwartz, James R.
    INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, 2021, 43 : S14 - S25
  • [28] A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in patients with epilepsy
    Palmese, CA
    Hamberger, MJ
    Weintraub, D
    Scarmeas, N
    Choi, H
    Hirsch, LJ
    EPILEPSIA, 2005, 46 : 265 - 266
  • [29] A double-blind, placebo-controlled trial of donepezil in patients with Parkinson's Disease and related dementia
    Brashear, A
    Kuhn, ER
    Lane, KA
    Farlow, MR
    Unverzagt, FW
    NEUROLOGY, 2004, 62 (07) : A524 - A525
  • [30] THE 24-WEEK INTERIM ANALYSIS RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY OF ATACICEPT IN PATIENTS WITH IGA NEPHROPATHY AND PERSISTENT PROTEINURIA
    Barratt, Jonathan
    Tumlin, James A.
    Suzuki, Yusuke
    Kao, Amy
    Aydemir, Aida
    Zima, Yulia
    Appel, Gerald
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 139 - 139
12345